- Classification of current anticancer immunotherapies.
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G. Galluzzi L, et al. Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.
- Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.
Aghlara-Fotovat S, Nash A, Kim B, Krencik R, Veiseh O. Aghlara-Fotovat S, et al. Drug Deliv Transl Res. 2021 Dec;11(6):2394-2413. doi: 10.1007/s13346-021-01018-0. Epub 2021 Jun 26. Drug Deliv Transl Res. 2021. PMID: 34176099 Review.
- Immune Checkpoint Therapies in Prostate Cancer.
Goswami S, Aparicio A, Subudhi SK. Goswami S, et al. Cancer J. 2016 Mar-Apr;22(2):117-20. doi: 10.1097/PPO.0000000000000176. Cancer J. 2016. PMID: 27111907 Free PMC article. Review.
- Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
Vacchelli E, Eggermont A, Fridman WH, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Oncoimmunology. 2013 May 1;2(5):e24238. doi: 10.4161/onci.24238. Oncoimmunology. 2013. PMID: 23762803 Free PMC article.
- Trial watch: Monoclonal antibodies in cancer therapy.
Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Oncoimmunology. 2013 Jan 1;2(1):e22789. doi: 10.4161/onci.22789. Oncoimmunology. 2013. PMID: 23482847 Free PMC article.